PCSK9 Inhibitors: From Nature's Lessons to Clinical Utility.
Raal FJ, Chilton R, Ranjith N, Rambiritch V, Leisegang RF, Ebrahim IO, Tonder AV, Shunmoogam N, Bouharati C, Musa MG, Karamchand S, Naidoo P, Blom DJ.
Raal FJ, et al. Among authors: naidoo p.
Endocr Metab Immune Disord Drug Targets. 2020;20(6):840-854. doi: 10.2174/1871530320666200213114138.
Endocr Metab Immune Disord Drug Targets. 2020.
PMID: 32053090
Review.